(Total Views: 79)
Posted On: 09/23/2022 9:16:15 AM
Post# of 25482
$MYNZ announced in late June that the company had enrolled the first patient in ColoFuture, an international clinical study assessing the potential to integrate a portfolio of novel gene expression (mRNA) biomarkers into ColoAlert.
(0)
(0)
